Loading…
Lobbying Spend
—
Filings
16
Firms Hired
1
Active Period
2010–2013
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Pharmaceutical Quality, Security, and Accountability Act
2013 · third_quarter · Firm: Polsinelli PC
Seeking comprehensive Medicare coverage of home infusion therapy; Medicare reform issues pertaining to homecare and infusion therapy, including an infusion therapy demonstration project and similar demonstration projects; Medicare Part B competitive bidding issues; Working with client to collect data to assist lobbying effort on Medicare coverage issue; working with client on Pharmaceutical Compounding Quality and Accountability Act (S. 959) and other drug compounding legislation
Client expense: — · Firm income: $30,000
Matched citations: S. 959
Pharmaceutical Quality, Security, and Accountability Act
2013 · second_quarter · Firm: Polsinelli PC
Seeking comprehensive Medicare coverage of home infusion therapy; Medicare reform issues pertaining to homecare and infusion therapy, including an infusion therapy demonstration project and similar demonstration projects; Medicare Part B competitive bidding issues; Working with client to collect data to assist lobbying effort on Medicare coverage issue; working with client on Pharmaceutical Compounding Quality and Accountability Act (S. 959) and other drug compounding legislation
Client expense: — · Firm income: $30,000
Matched citations: S. 959
Pharmaceutical Quality, Security, and Accountability Act
2013 · second_quarter · Firm: Polsinelli PC
Seeking comprehensive Medicare coverage of home infusion therapy; Medicare reform issues pertaining to homecare and infusion therapy, including an infusion therapy demonstration project and similar demonstration projects; Medicare Part B competitive bidding issues; Working with client to collect data to assist lobbying effort on Medicare coverage issue; working with client on Pharmaceutical Compounding Quality and Accountability Act (S. 959) and other drug compounding legislation
Client expense: — · Firm income: $30,000
Matched citations: S. 959
Source: Senate LDA